Adaphostin

Catalog No. :
ACPBIP203
CAS No. :
241127-58-2
Molecular Formula :
C24H27NO4
Molecular Weight :
393.48

IUPAC Name:adamantan-1-yl 4-((2,5-dihydroxybenzyl)amino)benzoate

Adaphostin structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25mg99%$103.00Login to see priceIn stockInquiry
50mg99%$174.00Login to see priceIn stockInquiry
100mg99%$295.00Login to see priceIn stockInquiry
250mg99%$561.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameAdaphostin
IUPAC Nameadamantan-1-yl 4-((2,5-dihydroxybenzyl)amino)benzoate
Molecular FormulaC24H27NO4
Molecular Weight393.48
SMILESO=C(OC12CC3CC(C2)CC(C3)C1)C4=CC=C(NCC5=CC(O)=CC=C5O)C=C4
InChI KeyYJZSUCFGHXQWDM-UHFFFAOYSA-N
Synonym1-adamantyl 4-[(2,5-dihydroxyphenyl)methylamino]benzoate;4-[[(2,5-Dihydroxyphenyl)methyl]amino]benzoicacidtricyclo[3.3.1.13,7]dec-1-ylester;Adaphostin;Benzoic acid, 4-[[(2,5-dihydroxyphenyl)methyl]amino]-, tricyclo[3.3.1.13,7]dec-1-yl ester;1-Adamantyl 4-((2;5-Dihydroxybenzyl)Amino)Benzoate;1-Adamantyl 4-((2,5-Dihydroxybenzyl)Amino)Benzoate;Apoptosis,tyrosine kinase,inhibit,Bcr-Abl,Adaphostin,chronic myelogenous leukemia,myeloid,Inhibitor,ROS,NSC-680410,p210Bcr/abl,NSC680410,CML
CAS No.241127-58-2

Synthetic Route by SureRoute

1. ACPBIP203 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPBIP203 route product structure diagram
    ACPBIP203241127-58-2 In Stock
Inquiry

2. ACPBIP203 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPBIP203 route product structure diagram
    ACPBIP203241127-58-2 In Stock
Inquiry

Comments (0)